Ertapenem-Containing Double-Carbapenem Therapy for Treatment of Infections Caused by Carbapenem-Resistant Klebsiella pneumoniae
Open Access
- 1 January 2016
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 60 (1) , 669-673
Abstract
We describe outcomes of patients with infections with carbapenem-resistant Klebsiella pneumoniae (CRKP) who received ertapenem-containing double-carbapenem therapy (ECDCT). Clinical success was observed in 7/18 (39%) patients overall: bloodstream infections, 3/7 (43%); pneumonia, 1/5 (20%); intraabdominal infections, 0/2 (0%); urinary tract infections, 2/3 (67%); and a skin and skin structure infection, 1/1 (100%). Microbiologic success was observed in 11/14 (79%) evaluable patients; 5/18 (28%) patients died. ECDCT may be effective for CRKP infections with limited treatment options.Keywords
This publication has 16 references indexed in Scilit:
- Effectiveness of a Double-Carbapenem Regimen for Infections in Humans Due to Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2013
- The Utility of Acute Physiology and Chronic Health Evaluation II Scores for Prediction of Mortality among Intensive Care Unit (ICU) and Non-ICU Patients with Methicillin-Resistant Staphylococcus aureus BacteremiaInfection Control & Hospital Epidemiology, 2012
- Global Spread of Carbapenemase-producing EnterobacteriaceaeEmerging Infectious Diseases, 2011
- Double-Carbapenem Therapy for Carbapenemase-Producing Klebsiella pneumoniaeAntimicrobial Agents and Chemotherapy, 2011
- Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time–kill assayInternational Journal of Antimicrobial Agents, 2011
- Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill PatientsAntimicrobial Agents and Chemotherapy, 2010
- Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distributionJournal of Antimicrobial Chemotherapy, 2009
- CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care settingAmerican Journal of Infection Control, 2008
- Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in EnterobacteriaceaeJournal of Clinical Microbiology, 2007
- Validation of a combined comorbidity indexJournal of Clinical Epidemiology, 1994